ToxSci Advance Access originally published online on February 19, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Toxicological Sciences 79, 82-89 (2004)
Toxicological Sciences vol. 79 no. 1 © Society of Toxicology; all rights reserved.
Human CD34+ Hematopoietic Progenitor Cells Are Sensitive Targets for Toxicity Induced by 1,4-Benzoquinone
CIIT Centers for Health Research, Research Triangle Park, North Carolina 27709
Received November 13, 2003; accepted January 27, 2004
Chronic human exposure to benzene has been linked to several hematopoietic disorders, including leukemia and lymphomas. Certain benzene metabolites, including benzoquinone (BQ), are genotoxic and mutagenic. Bone marrow stem cells are targets for benzene-induced cytotoxicity and DNA damage that could result in changes to the genome of these progenitor cells, thereby leading to hematopoietic disorders and cancers. Human bone marrow CD34+ hematopoietic progenitor cells (HPC) were exposed in vitro to 1,4-BQ to assess cytotoxicity, genotoxicity, and DNA damage responses and the molecular mechanisms associated with these events. CD34+ HPC from 10 men and 10 women were exposed to 0, 1, 5, 10, 15, or 20 µM of 1,4-BQ and analyzed 72 h later. Apoptosis and cytotoxicity were dose-dependent, with exposure to 10 µM 1,4-BQ resulting in approximately 60% cytotoxicity relative to untreated controls. A significant increase in the percentage of micronucleated CD34+ cells was detected in cultures treated with 1,4-BQ. In addition, the p21 mRNA level was elevated in 1,4-BQ-treated cells, suggesting that human CD34+ cells utilize the p53 pathway in response to 1,4-BQ-induced DNA damage. However, there were no significant changes in mRNA levels of the DNA repair genes ku80, rad51, xpa, xpc, and ape1 as well as p53 following treatment with 1,4-BQ. Although interindividual variations were evident in the cellular response to 1,4-BQ, there was no gender difference in the response overall. These results show that human CD34+ cells are sensitive targets for 1,4-BQ toxicity that use the p53 DNA damage response pathway in response to genotoxic stress. Human CD34+ HPC will be useful for testing the toxicity of other benzene metabolites and various hematotoxic chemicals.
Key Words: benzene; benzoquinone; CD34; hematopoietic progenitor cells; DNA repair; cytotoxicity.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  H.-H. L. Hong, T.-V. T. Ton, Y. Kim, N. Wakamatsu, N. P. Clayton, P.-C. Chan, R. C. Sills, and S. A. Lahousse Genetic Alterations in K-ras and p53 Cancer Genes in Lung Neoplasms from B6C3F1 Mice Exposed to Cumene Toxicol Pathol, July 1, 2008; 36(5): 720 - 726. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Ahmad Khan Short Review: Benzene's toxicity: a consolidated short review of human and animal studies Human and Experimental Toxicology, September 1, 2007; 26(9): 677 - 685. [Abstract] [PDF]
|
|
|
|
|
|
C. D. Houle, T.-V. T. Ton, N. Clayton, J. Huff, H.-H. L. Hong, and R. C. Sills Frequent p53 and H-ras Mutations in Benzene- and Ethylene Oxide-Induced Mammary Gland Carcinomas from B6C3F1 Mice Toxicol Pathol, October 1, 2006; 34(6): 752 - 762. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Trosko and B. L. Upham The emperor wears no clothes in the field of carcinogen risk assessment: ignored concepts in cancer risk assessment Mutagenesis, March 1, 2005; 20(2): 81 - 92. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Lan, L. Zhang, G. Li, R. Vermeulen, R. S. Weinberg, M. Dosemeci, S. M. Rappaport, M. Shen, B. P. Alter, Y. Wu, et al. Hematotoxicity in Workers Exposed to Low Levels of Benzene Science, December 3, 2004; 306(5702): 1774 - 1776. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Faiola, E. S. Fuller, V. A. Wong, L. Pluta, D. J. Abernethy, J. Rose, and L. Recio Exposure of Hematopoietic Stem Cells to Benzene or 1,4-Benzoquinone Induces Gender-Specific Gene Expression Stem Cells, September 1, 2004; 22(5): 750 - 758. [Abstract] [Full Text] [PDF]
|
|